Pub Date : 2025-05-30eCollection Date: 2025-11-01DOI: 10.1002/jpr3.70036
Kenneth Grant, Jenilee Pohle, Robert Tran, Roy Nattiv
Objectives: The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti-drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have focused largely on white, non-Hispanic patients and have demonstrated variable benefits. This study evaluated the utility of CIT in preventing ADAs in a pediatric IBD population with high Hispanic representation.
Methods: We reviewed the charts of patients undergoing biologic induction at the Miller Children's Pediatric IBD Center between 2013 and 2023. Patients with missing therapeutic drug monitoring data or incomplete follow-up were excluded. Categorical variables were compared using chi-square or Fisher's exact tests, and continuous variables were analyzed using t tests. Multivariate logistic regression identified independent predictors of ADA formation.
Results: Of 163 pediatric patients, 75 had Crohn's disease (CD) and 80 had ulcerative colitis (UC). High-dose infliximab (IFX) was protective against ADA formation (p < 0.001), as were corticosteroids (p = 0.029). UC patients were more likely to receive corticosteroids at induction (CD: 27/75, UC: 45/80; p = 0.011). Among UC patients, CIT reduced ADA formation (odds ratio: 0.18; 95% confidence interval: 0.04-0.73; p = 0.031). Hispanic patients were more likely to have UC (CD: 18/73, UC: 46/80; p < 0.001). Hispanic UC patients had shorter times to biologic initiation (p = 0.025) and were more likely to receive both high-dose IFX and corticosteroids at the time of biologic induction (p = 0.044).
Conclusions: High-dose IFX may obviate the need for CIT in ADA prevention in pediatric IBD. UC patients may benefit more from CIT than CD patients. Disparities in treatment timing and medication use among Hispanic UC patients highlight the need for further investigation.
目的:在儿童炎症性肠病(IBD)患者中,生物治疗的使用正在增加。然而,药物清除率和抗药物抗体(ADAs)的增加可能会降低疗效。历史上,伴随免疫调节疗法(CIT)已被用于预防ADA的形成。评估CIT的儿科研究主要集中在白人、非西班牙裔患者身上,并显示出不同的益处。本研究评估了CIT在西班牙裔儿童IBD人群中预防ADAs的效用。方法:我们回顾了2013年至2023年在米勒儿童儿科IBD中心接受生物诱导的患者图表。排除治疗药物监测数据缺失或随访不完整的患者。分类变量采用卡方检验或Fisher精确检验进行比较,连续变量采用t检验进行分析。多元逻辑回归确定了ADA形成的独立预测因素。结果:163例儿童患者中,75例患有克罗恩病(CD), 80例患有溃疡性结肠炎(UC)。大剂量英夫利昔单抗(IFX)对ADA形成有保护作用(p p = 0.029)。UC患者更有可能在诱导时接受皮质类固醇(CD: 27/75, UC: 45/80; p = 0.011)。在UC患者中,CIT减少ADA形成(优势比:0.18;95%可信区间:0.04-0.73;p = 0.031)。西班牙裔患者更有可能发生UC (CD: 18/73, UC: 46/80; p = 0.025),在生物诱导时更有可能同时接受高剂量IFX和皮质类固醇(p = 0.044)。结论:在儿童IBD ADA预防中,大剂量IFX可能会避免CIT的需要。UC患者可能比CD患者从CIT中获益更多。西班牙裔UC患者在治疗时机和药物使用方面的差异突出了进一步调查的必要性。
{"title":"Impact of biologic induction dose and concomitant drugs on anti-drug antibody formation in a pediatric IBD cohort with high Hispanic representation.","authors":"Kenneth Grant, Jenilee Pohle, Robert Tran, Roy Nattiv","doi":"10.1002/jpr3.70036","DOIUrl":"10.1002/jpr3.70036","url":null,"abstract":"<p><strong>Objectives: </strong>The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti-drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have focused largely on white, non-Hispanic patients and have demonstrated variable benefits. This study evaluated the utility of CIT in preventing ADAs in a pediatric IBD population with high Hispanic representation.</p><p><strong>Methods: </strong>We reviewed the charts of patients undergoing biologic induction at the Miller Children's Pediatric IBD Center between 2013 and 2023. Patients with missing therapeutic drug monitoring data or incomplete follow-up were excluded. Categorical variables were compared using chi-square or Fisher's exact tests, and continuous variables were analyzed using <i>t</i> tests. Multivariate logistic regression identified independent predictors of ADA formation.</p><p><strong>Results: </strong>Of 163 pediatric patients, 75 had Crohn's disease (CD) and 80 had ulcerative colitis (UC). High-dose infliximab (IFX) was protective against ADA formation (<i>p</i> < 0.001), as were corticosteroids (<i>p</i> = 0.029). UC patients were more likely to receive corticosteroids at induction (CD: 27/75, UC: 45/80; <i>p</i> = 0.011). Among UC patients, CIT reduced ADA formation (odds ratio: 0.18; 95% confidence interval: 0.04-0.73; <i>p</i> = 0.031). Hispanic patients were more likely to have UC (CD: 18/73, UC: 46/80; <i>p</i> < 0.001). Hispanic UC patients had shorter times to biologic initiation (<i>p</i> = 0.025) and were more likely to receive both high-dose IFX and corticosteroids at the time of biologic induction (<i>p</i> = 0.044).</p><p><strong>Conclusions: </strong>High-dose IFX may obviate the need for CIT in ADA prevention in pediatric IBD. UC patients may benefit more from CIT than CD patients. Disparities in treatment timing and medication use among Hispanic UC patients highlight the need for further investigation.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 4","pages":"437-443"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12611574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-26eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70025
Michael A Manfredi, Reinaldo P Alvarez, Katsuhiro Arai, Huma A Cheema, Andy Darma, Mamoun Elawad, Claudio Iglesias, Matjaz Homan, Omar I Saadah, Catharine M Walsh, Lissy de Ridder
This is a comprehensive review of pediatric foreign body (FB) ingestions, emphasizing the global burden, epidemiology, and management strategies. Predominantly occurring in children under 6, with a peak between 6 months and 3 years, these incidents pose significant health risks with substantial regional variations in ingested objects-ranging from household items to caustic substances. The pathophysiological effects of ingestions are outlined, highlighting specific dangers associated with button batteries, sharp objects, and caustic agents, which can lead to severe tissue damage and long-term complications. A survey of (70) pediatric gastroenterologists from FISPGHAN societies revealed varied regional practices in the frequency of different FB ingestions with food impaction highest in North America and Ocenaia and caustic ingestion more common is Asia. Button batterers were serious concerns across all regions. Management approaches, specifically intubation practice varied across regions. A review of management protocols for different types of ingestions are provided, emphasizing the urgency of endoscopic removal and follow-up care. Prevention strategies are critical, with a focus on public health interventions, legislation, and education to mitigate the risks associated with FB and caustic ingestions. This report underscores the need for enhanced preventive measures and uniform management guidelines to reduce the incidence and improve outcomes of pediatric ingestions worldwide.
{"title":"Global insights on the diagnosis, management, and prevention of pediatric ingestions: A report from the FISPGHAN expert panel.","authors":"Michael A Manfredi, Reinaldo P Alvarez, Katsuhiro Arai, Huma A Cheema, Andy Darma, Mamoun Elawad, Claudio Iglesias, Matjaz Homan, Omar I Saadah, Catharine M Walsh, Lissy de Ridder","doi":"10.1002/jpr3.70025","DOIUrl":"10.1002/jpr3.70025","url":null,"abstract":"<p><p>This is a comprehensive review of pediatric foreign body (FB) ingestions, emphasizing the global burden, epidemiology, and management strategies. Predominantly occurring in children under 6, with a peak between 6 months and 3 years, these incidents pose significant health risks with substantial regional variations in ingested objects-ranging from household items to caustic substances. The pathophysiological effects of ingestions are outlined, highlighting specific dangers associated with button batteries, sharp objects, and caustic agents, which can lead to severe tissue damage and long-term complications. A survey of (70) pediatric gastroenterologists from FISPGHAN societies revealed varied regional practices in the frequency of different FB ingestions with food impaction highest in North America and Ocenaia and caustic ingestion more common is Asia. Button batterers were serious concerns across all regions. Management approaches, specifically intubation practice varied across regions. A review of management protocols for different types of ingestions are provided, emphasizing the urgency of endoscopic removal and follow-up care. Prevention strategies are critical, with a focus on public health interventions, legislation, and education to mitigate the risks associated with FB and caustic ingestions. This report underscores the need for enhanced preventive measures and uniform management guidelines to reduce the incidence and improve outcomes of pediatric ingestions worldwide.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"274-287"},"PeriodicalIF":0.0,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-22eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70030
Christine Rungoe, Stefan Stender, Nawar Dalila, Emil D Bartels, Christian Jakobsen
We present a case of a young female patient with persistent and severe fat-soluble vitamin deficiency since infancy. Despite extensive investigations during childhood, the underlying cause remained elusive. The patient was generally asymptomatic while receiving continuous vitamin subsidy. Exome sequencing performed at age 18 revealed a homozygous missense variant (Pro65Leu) in the gene SLC10A2, which encodes a bile acid transporter in the ileum. A bile retention scan showed severe bile acid malabsorption, with only 1.6% of radioactively labeled bile acids retained 7 days after intake. Treatment with a bile acid sequestrant was attempted but discontinued due to side effects and no significant effect on intestinal vitamin uptake. This case highlights the importance of early genetic testing in patients with unexplained fat-soluble vitamin deficiency. It also emphasizes the need for further research to elucidate the clinical spectrum and management of primary bile acid malabsorption due to SLC10A2 deficiency.
{"title":"Homozygosity for a variant in <i>SLC10A2</i> and infancy onset severe fat-soluble vitamin deficiency due to bile acid malabsorption.","authors":"Christine Rungoe, Stefan Stender, Nawar Dalila, Emil D Bartels, Christian Jakobsen","doi":"10.1002/jpr3.70030","DOIUrl":"10.1002/jpr3.70030","url":null,"abstract":"<p><p>We present a case of a young female patient with persistent and severe fat-soluble vitamin deficiency since infancy. Despite extensive investigations during childhood, the underlying cause remained elusive. The patient was generally asymptomatic while receiving continuous vitamin subsidy. Exome sequencing performed at age 18 revealed a homozygous missense variant (Pro65Leu) in the gene <i>SLC10A2</i>, which encodes a bile acid transporter in the ileum. A bile retention scan showed severe bile acid malabsorption, with only 1.6% of radioactively labeled bile acids retained 7 days after intake. Treatment with a bile acid sequestrant was attempted but discontinued due to side effects and no significant effect on intestinal vitamin uptake. This case highlights the importance of early genetic testing in patients with unexplained fat-soluble vitamin deficiency. It also emphasizes the need for further research to elucidate the clinical spectrum and management of primary bile acid malabsorption due to <i>SLC10A2</i> deficiency.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"296-299"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70032
Kathleen Ordas, Joy Brusenback, Sahana Ummadi, Shannon Tocchio, Razan Alkhouri, Soha Shah
Gastrointestinal (GI) bleeding can be a common symptom in the pediatric population. Vascular malformations, which cause symptoms based on their location and effect on surrounding structures, are an uncommon cause of GI bleeding. We present the case of a 6-year-old male with a 1-year history of hematochezia, constipation, and microcytic anemia. Physical exam demonstrated a firm, mobile, non-circumferential anal mass measuring 4 cm in diameter, and located predominantly at the right-anterior bowel wall. Initial imaging, including abdominal radiograph and abdominal ultrasound, was unremarkable. Colonoscopy was visually and histologically negative. Magnetic resonance imaging of the pelvis showed an extensive pelvic venous-lymphatic malformation in the left hemipelvis, with extension to the right hemipelvis and left lower extremity, displacement of the rectum and colon, and protrusion into the anal canal. He was started on Sirolimus with symptom improvement. This case discusses a rare presentation of a pediatric vascular malformation presenting with a protruding anal mass.
{"title":"Hematochezia: An abnormal presenting symptom of an extensive vascular malformation in a 6-year-old boy.","authors":"Kathleen Ordas, Joy Brusenback, Sahana Ummadi, Shannon Tocchio, Razan Alkhouri, Soha Shah","doi":"10.1002/jpr3.70032","DOIUrl":"10.1002/jpr3.70032","url":null,"abstract":"<p><p>Gastrointestinal (GI) bleeding can be a common symptom in the pediatric population. Vascular malformations, which cause symptoms based on their location and effect on surrounding structures, are an uncommon cause of GI bleeding. We present the case of a 6-year-old male with a 1-year history of hematochezia, constipation, and microcytic anemia. Physical exam demonstrated a firm, mobile, non-circumferential anal mass measuring 4 cm in diameter, and located predominantly at the right-anterior bowel wall. Initial imaging, including abdominal radiograph and abdominal ultrasound, was unremarkable. Colonoscopy was visually and histologically negative. Magnetic resonance imaging of the pelvis showed an extensive pelvic venous-lymphatic malformation in the left hemipelvis, with extension to the right hemipelvis and left lower extremity, displacement of the rectum and colon, and protrusion into the anal canal. He was started on Sirolimus with symptom improvement. This case discusses a rare presentation of a pediatric vascular malformation presenting with a protruding anal mass.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"300-304"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70033
Abebe Habtamu, Tenagne Million
Objectives: This study aimed to assess the nutritional status of children aged 1 month to 14 years during admission and discharge at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia.
Methods: A prospective descriptive study design was employed, utilizing structured and nonstructured questionnaires to collect data. A total of 400 children, aged 1 month to 14 years, were included in the study. Anthropometric measurements were conducted to determine their nutritional status. Parents were interviewed to gather information on socio-demographic characteristics, clinical history, and feeding patterns of the children. Descriptive analysis was performed using SPSS software version 23.0. Chi-square tests were utilized to identify differences, while odds ratios (ORs) were employed to assess and quantify associations between categorical outcomes. ORs were reported with 95% confidence intervals (CIs). A p-value less than 0.05 was considered statistically significant.
Results: The study included 400 children, consisting of 245 (61.3%) males and 155 (38.8%) females. During admission, the assessment of nutritional status revealed that 301 (75.3%) of the children were classified as normal, 99 (24.7%) undernourished. On discharge 228 (57.0%) normal, 172 (43.0%) undernourished. Gender was found to be significantly associated with undernutrition during admission. Females were 2.376 times more likely to be exposed to undernutrition compared to males, with a 95% CI for the OR ranging from 1.497 to 3.773.
Conclusion: The prevalence of undernutrition was significantly higher on discharge than during admission. Therefore, providing high-quality nursing care is crucial for children admitted to the hospital.
{"title":"Nutritional assessment of children admitted at Tikur Anbessa Specialized Hospital, School of Medicine, College of Health Sciences.","authors":"Abebe Habtamu, Tenagne Million","doi":"10.1002/jpr3.70033","DOIUrl":"10.1002/jpr3.70033","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the nutritional status of children aged 1 month to 14 years during admission and discharge at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia.</p><p><strong>Methods: </strong>A prospective descriptive study design was employed, utilizing structured and nonstructured questionnaires to collect data. A total of 400 children, aged 1 month to 14 years, were included in the study. Anthropometric measurements were conducted to determine their nutritional status. Parents were interviewed to gather information on socio-demographic characteristics, clinical history, and feeding patterns of the children. Descriptive analysis was performed using SPSS software version 23.0. Chi-square tests were utilized to identify differences, while odds ratios (ORs) were employed to assess and quantify associations between categorical outcomes. ORs were reported with 95% confidence intervals (CIs). A <i>p</i>-value less than 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The study included 400 children, consisting of 245 (61.3%) males and 155 (38.8%) females. During admission, the assessment of nutritional status revealed that 301 (75.3%) of the children were classified as normal, 99 (24.7%) undernourished. On discharge 228 (57.0%) normal, 172 (43.0%) undernourished. Gender was found to be significantly associated with undernutrition during admission. Females were 2.376 times more likely to be exposed to undernutrition compared to males, with a 95% CI for the OR ranging from 1.497 to 3.773.</p><p><strong>Conclusion: </strong>The prevalence of undernutrition was significantly higher on discharge than during admission. Therefore, providing high-quality nursing care is crucial for children admitted to the hospital.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"248-254"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70034
Antonia F Ovale, Cassandra Charles, Janet Rosenbaum, Priscila Villalba-Davila, Shagun Sharma, Saema Khandakar, Thomas Wallach
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has known liver tropism. Multiple reports and studies demonstrated liver injury early in the pandemic. This retrospective cross-sectional comparison evaluates predictors of transaminase elevation during acute SARS-CoV2 infection, with particular interest in evaluating whether vaccination is associated with transaminase elevations. We extracted electronic medical record data for pediatric SARS-CoV2 patients presenting at safety net hospitals in Brooklyn, NY, between March 2020 and March 2022 with a coincident comprehensive metabolic panel, without multisystem inflammatory syndrome in children, prior liver disease and sickle cell disease (n = 133): 79.2% Black and 87% non-Hispanic. Transaminase elevation was more common among younger patients and patients requiring hospitalization or intensive care unit care. Vaccination was associated with lower quantitative levels of transaminase elevation but not the binary indicator for elevated transaminases. In aggregate, our results suggest transaminase elevation is a function of SARS-CoV2 disease severity.
{"title":"Severe acute respiratory syndrome coronavirus 2 transaminase elevation likely of non-hepatic origin, with protection from older age and vaccination.","authors":"Antonia F Ovale, Cassandra Charles, Janet Rosenbaum, Priscila Villalba-Davila, Shagun Sharma, Saema Khandakar, Thomas Wallach","doi":"10.1002/jpr3.70034","DOIUrl":"10.1002/jpr3.70034","url":null,"abstract":"<p><p>Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has known liver tropism. Multiple reports and studies demonstrated liver injury early in the pandemic. This retrospective cross-sectional comparison evaluates predictors of transaminase elevation during acute SARS-CoV2 infection, with particular interest in evaluating whether vaccination is associated with transaminase elevations. We extracted electronic medical record data for pediatric SARS-CoV2 patients presenting at safety net hospitals in Brooklyn, NY, between March 2020 and March 2022 with a coincident comprehensive metabolic panel, without multisystem inflammatory syndrome in children, prior liver disease and sickle cell disease (<i>n</i> = 133): 79.2% Black and 87% non-Hispanic. Transaminase elevation was more common among younger patients and patients requiring hospitalization or intensive care unit care. Vaccination was associated with lower quantitative levels of transaminase elevation but not the binary indicator for elevated transaminases. In aggregate, our results suggest transaminase elevation is a function of SARS-CoV2 disease severity.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"255-261"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70035
Razan Alkhouri, Craig Wong, Allyson Richards, David Martin, Joshua Hanson, Rasha Elmaoued, Rajmohan Dharmaraj, Ioannis Kalampokis
Inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis, is a chronic inflammatory condition affecting the gastrointestinal tract. Treatment for IBD depends on disease severity and can include medical and surgical management. Advances in treatment and the availability of biologics have significantly reduced the need for surgical interventions. Eosinophilic mesenteric vasculitis (EMV) is a rare form of intestinal vasculitis that can mimic IBD. Diagnosis of EMV is challenging as it requires full-thickness biopsies. It can be mistaken for CD due to its response to steroids, which are a first-line therapy for EMV; however, EMV typically does not respond to other IBD-specific therapies. We present the case of a 15-year-old girl with a history of autoimmune hemolytic anemia who initially appeared to have CD but was diagnosed with EMV following a lack of clinical remission and persistence of the colonic stricture despite biologic therapy, which ultimately led to bowel obstruction symptoms requiring surgical resection.
{"title":"Eosinophilic mesenteric vasculitis presenting as inflammatory bowel disease.","authors":"Razan Alkhouri, Craig Wong, Allyson Richards, David Martin, Joshua Hanson, Rasha Elmaoued, Rajmohan Dharmaraj, Ioannis Kalampokis","doi":"10.1002/jpr3.70035","DOIUrl":"10.1002/jpr3.70035","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis, is a chronic inflammatory condition affecting the gastrointestinal tract. Treatment for IBD depends on disease severity and can include medical and surgical management. Advances in treatment and the availability of biologics have significantly reduced the need for surgical interventions. Eosinophilic mesenteric vasculitis (EMV) is a rare form of intestinal vasculitis that can mimic IBD. Diagnosis of EMV is challenging as it requires full-thickness biopsies. It can be mistaken for CD due to its response to steroids, which are a first-line therapy for EMV; however, EMV typically does not respond to other IBD-specific therapies. We present the case of a 15-year-old girl with a history of autoimmune hemolytic anemia who initially appeared to have CD but was diagnosed with EMV following a lack of clinical remission and persistence of the colonic stricture despite biologic therapy, which ultimately led to bowel obstruction symptoms requiring surgical resection.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"316-319"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-13eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70028
Minna M Wieck, Sujit K Jha
{"title":"Duodenal duplication cyst causing partial obstruction in a neonate.","authors":"Minna M Wieck, Sujit K Jha","doi":"10.1002/jpr3.70028","DOIUrl":"10.1002/jpr3.70028","url":null,"abstract":"","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"322-324"},"PeriodicalIF":0.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-12eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70027
Saskia Vande Velde, Stephanie Van Biervliet, Ann J M Van Gils, Pauline De Bruyne, Ruth De Bruyne, Lucas Matthyssens, Dirk Van de Putte, Katrien Van Renterghem
Kirberg et al. described in 2016 a one-step gastrostomy tube placement, the 'pull-introducer' technique, designed for small-for-gestational-age neonates, combining two endoscopic techniques. Nine infants (weight 3.4-8.1 kg) in our centre required a gastrostomy placement (two infants) or a combined gastrostomy placement and Nissen fundoplication (seven infants). A single-stage balloon gastrostomy was preferred in all cases because of a significant anaesthetic risk. The pull-introducer method was chosen because the commercially available one-step balloon gastrostomy gastropexy devices were considered too large. There were no immediate or long-term complications (except local infection). All nine infants were discharged from the hospital as planned. After 6 months, the balloon gastrostomy tube was replaced with a balloon button or balloon gastrostomy tube.
{"title":"Laparoscopic-assisted 'pull-introducer technique' for gastrostomy tube placement in small infants: A single-centre experience.","authors":"Saskia Vande Velde, Stephanie Van Biervliet, Ann J M Van Gils, Pauline De Bruyne, Ruth De Bruyne, Lucas Matthyssens, Dirk Van de Putte, Katrien Van Renterghem","doi":"10.1002/jpr3.70027","DOIUrl":"10.1002/jpr3.70027","url":null,"abstract":"<p><p>Kirberg et al. described in 2016 a one-step gastrostomy tube placement, the 'pull-introducer' technique, designed for small-for-gestational-age neonates, combining two endoscopic techniques. Nine infants (weight 3.4-8.1 kg) in our centre required a gastrostomy placement (two infants) or a combined gastrostomy placement and Nissen fundoplication (seven infants). A single-stage balloon gastrostomy was preferred in all cases because of a significant anaesthetic risk. The pull-introducer method was chosen because the commercially available one-step balloon gastrostomy gastropexy devices were considered too large. There were no immediate or long-term complications (except local infection). All nine infants were discharged from the hospital as planned. After 6 months, the balloon gastrostomy tube was replaced with a balloon button or balloon gastrostomy tube.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"262-265"},"PeriodicalIF":0.0,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-17eCollection Date: 2025-08-01DOI: 10.1002/jpr3.70022
Erica Chang, Caroline Chinchilla Putzeys, Edward Hoffenberg, Ashish Patel, Elizabeth Hilow, Brad Pasternak
Genital edema is a rare presentation of Crohn's disease (CD), also known as metastatic CD (MCD). This may precede, co-occur with, or follow gastrointestinal symptoms and present a diagnostic challenge. We aimed to characterize the features, clinical courses, pathogenesis, and outcomes of patients with MCD to increase understanding and promote timely management. A retrospective review of four patients diagnosed with MCD was conducted at Phoenix Children's and Children's Hospital Colorado. Patients presented with painful and painless penoscrotal swelling with and without erythema. Scrotal histopathology revealed granulomatous inflammation, and genetic testing identified pathogenic variants in NOD2, COL7A1, and Chek2, as well as additional variants of uncertain significance. Treatments included antibiotics, steroids, biologics, and methotrexate with mixed responses. Further research and clinical trials are needed to better understand the pathogenesis and develop best practices.
{"title":"Genital Crohn's disease in pediatrics and genetic associations.","authors":"Erica Chang, Caroline Chinchilla Putzeys, Edward Hoffenberg, Ashish Patel, Elizabeth Hilow, Brad Pasternak","doi":"10.1002/jpr3.70022","DOIUrl":"10.1002/jpr3.70022","url":null,"abstract":"<p><p>Genital edema is a rare presentation of Crohn's disease (CD), also known as metastatic CD (MCD). This may precede, co-occur with, or follow gastrointestinal symptoms and present a diagnostic challenge. We aimed to characterize the features, clinical courses, pathogenesis, and outcomes of patients with MCD to increase understanding and promote timely management. A retrospective review of four patients diagnosed with MCD was conducted at Phoenix Children's and Children's Hospital Colorado. Patients presented with painful and painless penoscrotal swelling with and without erythema. Scrotal histopathology revealed granulomatous inflammation, and genetic testing identified pathogenic variants in NOD2, COL7A1, and Chek2, as well as additional variants of uncertain significance. Treatments included antibiotics, steroids, biologics, and methotrexate with mixed responses. Further research and clinical trials are needed to better understand the pathogenesis and develop best practices.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 3","pages":"266-273"},"PeriodicalIF":0.0,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}